Who
Woodrow D. Anderson
Chief Accounting Officer
Company insider
Files Form 4 as: Chief Accounting Officer, Indivior Pharmaceuticals.
In numbers
- Trades disclosed
- 20
- Buys
- 2
- Sells
- 0
- Bought
- $216K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Feb 2026
- Last trade
- 27 Aug 2026
- Last filed
- 27 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Aug 2026filed 27 Aug 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $54K1,500 at $35.69 | filing |
| 27 Aug 2026filed 27 Aug 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $54K1,500 at $35.69 | filing |
| 5 Aug 2026filed 5 Aug 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $54K1,500 at $36.28 | filing |
| 5 Aug 2026filed 5 Aug 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $54K1,500 at $36.28 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —18,364 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $265K8,283 at $31.98 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —5,946 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —23,975 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —5,946 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $86K2,682 at $31.98 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —23,975 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —5,946 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —18,364 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $265K8,283 at $31.98 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —5,946 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $86K2,682 at $31.98 | filing |
| 10 Feb 2026filed 12 Feb 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,903 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,903 at $0.00 | filing |
| 9 Feb 2026filed 12 Feb 2026 | INDV Indivior Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —23,975 at $0.00 | filing |
| 9 Feb 2026filed 12 Feb 2026 | INDV Indivior Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —23,975 at $0.00 | filing |
News
Analyzing Indivior (NASDAQ:INDV) and Palisade Bio (NASDAQ:PALI)INDV · dailypolitical.com · 24 Oct 2026Contrasting Orion OYJ (OTCMKTS:ORINY) & Indivior (NASDAQ:INDV)INDV · themarketsdaily.com · 19 Oct 2026
0 headlines in the last 90 days name Woodrow D. Anderson; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.